FDA Drug recall D-0070-2019
Cicatricure, Scar Cream + Sunscreen SPF 30 (avobenzone 3%, octocrylene 10%, oxybenzone 6%), 0.7 oz. (19.8 g) tube, Distributed by: Genomma…
- FDA Drug
- Class III
- terminated
- Published 2018-10-24
On 2018-10-24 the FDA classified a Class III recall of Cicatricure, Scar Cream + Sunscreen SPF 30 (avobenzone 3%, octocrylene 10%, oxybenzone 6%), 0.7 oz. (19.8 g) tube, Distributed by: Genomma… by Product Quest Manufacturing, citing subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0070-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-08-03 |
| Published | 2018-10-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Product Quest Manufacturing |
| Distribution | US |
Product
Cicatricure, Scar Cream + Sunscreen SPF 30 (avobenzone 3%, octocrylene 10%, oxybenzone 6%), 0.7 oz. (19.8 g) tube, Distributed by: Genomma Lab USA Inc., Houston, TX 77027, UPC 6 50067 00018 7.
Reason
Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.
Identifiers
| upc | 650067000187 |
|---|---|
| code_info | Lot: 163241K, Exp. October 2018 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0070-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.